Search Results

There are 3614 results for: content related to: Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: Report of 2 cases

  1. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model

    Journal of Oral Pathology & Medicine

    Volume 41, Issue 10, November 2012, Pages: 788–792, S. Saracino, R. A. Canuto, M. Maggiora, M. Oraldi, M. Scoletta, L. Ciuffreda, A. M. Vandone, S. Carossa, M. Mozzati and G. Muzio

    Article first published online : 31 MAY 2012, DOI: 10.1111/j.1600-0714.2012.01173.x

  2. You have free access to this content
    Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis

    Journal of Bone and Mineral Research

    Volume 27, Issue 10, October 2012, Pages: 2130–2143, J Ignacio Aguirre, Mohammed P Akhter, Donald B Kimmel, Jennifer E Pingel, Alyssa Williams, Marda Jorgensen, Lakshmyya Kesavalu and Thomas J Wronski

    Article first published online : 18 SEP 2012, DOI: 10.1002/jbmr.1669

  3. Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment

    Internal Medicine Journal

    Volume 39, Issue 5, May 2009, Pages: 304–316, M. Dickinson, H. M. Prince, S. Kirsa, A. Zannettino, S. D. J. Gibbs, L. Mileshkin, J. O'Grady, J. F. Seymour, J. Szer, N. Horvath and D. E. Joshua

    Article first published online : 3 NOV 2008, DOI: 10.1111/j.1445-5994.2008.01824.x

  4. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 47–54, Ana O. Hoff, Bela Toth, Mimi Hu, Gabriel N. Hortobagyi and Robert F. Gagel

    Article first published online : 28 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05771.x

  5. Denosumab for the Treatment of Osteoporosis and Cancer-Related Conditions

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 1, January 2012, Pages: 123–133, E M Lewiecki and J P Bilezikian

    Article first published online : 7 DEC 2011, DOI: 10.1038/clpt.2011.268

  6. You have free access to this content
    Final 5-year results of Z-FAST trial


    Volume 118, Issue 5, 1 March 2012, Pages: 1192–1201, Adam M. Brufsky, W. Graydon Harker, J. Thaddeus Beck, Linda Bosserman, Charles Vogel, Christopher Seidler, Lixian Jin, Ghulam Warsi, Eliza Argonza-Aviles, John Hohneker, Solveig G. Ericson and Edith A. Perez

    Article first published online : 10 OCT 2011, DOI: 10.1002/cncr.26313

  7. Bisphosphonates and other bone agents for breast cancer

    Intervention Review

    The Cochrane Library

    Matthew HF Wong, Martin R Stockler and Nick Pavlakis

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD003474.pub3

  8. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw

    Journal of Oral Pathology & Medicine

    Volume 39, Issue 5, May 2010, Pages: 390–396, Matteo Biasotto, Silvia Chiandussi, Serena Zacchigna, Silvia Moimas, Franca Dore, Gabriele Pozzato, Fabio Cavalli, Fabrizio Zanconati, Luca Contardo, Mauro Giacca and Roberto Di Lenarda

    Article first published online : 28 FEB 2010, DOI: 10.1111/j.1600-0714.2009.00878.x

  9. You have full text access to this OnlineOpen article
    Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group

    Cancer Science

    Volume 105, Issue 8, August 2014, Pages: 989–995, Haruyasu Murakami, Takeharu Yamanaka, Takashi Seto, Kenji Sugio, Isamu Okamoto, Toshiyuki Sawa, Tomonori Hirashima, Koji Takeda, Shinji Atagi, Masahiro Fukuoka, Yoichi Nakanishi, Kazuhiko Nakagawa and Nobuyuki Yamamoto

    Article first published online : 12 JUL 2014, DOI: 10.1111/cas.12448

  10. The use of bisphosphonates in cancer treatment

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 3–14, Robert Coleman

    Article first published online : 28 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05766.x

  11. The use of zoledronic acid in pediatric cancer patients

    Pediatric Blood & Cancer

    Volume 56, Issue 4, April 2011, Pages: 610–614, Keith J. August, Amanda Dalton, Howard M. Katzenstein, Bradley George, Thomas A. Olson, Karen Wasilewski-Masker and Louis B. Rapkin

    Article first published online : 23 DEC 2010, DOI: 10.1002/pbc.22681

  12. The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function

    The Journal of Clinical Pharmacology

    Volume 43, Issue 2, February 2003, Pages: 154–162, Dr. Andrej Skerjanec, Dr. James Berenson, Dr. ChyiHung Hsu, Dr. Pierre Major, Dr. Wilson H. Miller Jr., Ms. Christina Ravera, Dr. Horst Schran, Dr. John Seaman and Dr. Felix Waldmeier

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270002239824

  13. Pharmacologic profile of zoledronic acid: A highly potent inhibitor of bone resorption

    Drug Development Research

    Volume 55, Issue 4, April 2002, Pages: 210–224, Jonathan R. Green and Michael J. Rogers

    Article first published online : 21 JUN 2002, DOI: 10.1002/ddr.10071

  14. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition

    Journal of Oral Pathology & Medicine

    Volume 41, Issue 9, October 2012, Pages: 713–720, Somying Patntirapong, Weerachai Singhatanadgit, Chatvadee Chanruangvanit, Kwankamol Lavanrattanakul and Yodhathai Satravaha

    Article first published online : 5 MAY 2012, DOI: 10.1111/j.1600-0714.2012.01154.x

  15. You have free access to this content
    A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

    Journal of Bone and Mineral Research

    Volume 26, Issue 9, September 2011, Pages: 2261–2270, Ian R Reid, Kenneth Lyles, Guoqin Su, Jacques P Brown, John P Walsh, Javier del Pino-Montes, Paul D Miller, William D Fraser, Susan Cafoncelli, Christina Bucci-Rechtweg and David J Hosking

    Article first published online : 19 AUG 2011, DOI: 10.1002/jbmr.438

  16. You have free access to this content
    Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis

    BJU International

    Volume 109, Issue 3, February 2012, Pages: 394–400, Kouji Izumi, Atsushi Mizokami, Shingo Itai, Takashi Shima, Kazuyoshi Shigehara, Sotaro Miwa, Yuji Maeda, Hiroyuki Konaka, Eitetsu Koh and Mikio Namiki

    Article first published online : 23 MAY 2011, DOI: 10.1111/j.1464-410X.2011.10192.x

  17. You have free access to this content
    Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

    Journal of Bone and Mineral Research

    Volume 23, Issue 6, June 2008, Pages: 826–836, Ana O Hoff, Béla B Toth, Kadri Altundag, Marcella M Johnson, Carla L Warneke, Mimi Hu, Ajay Nooka, Gilbert Sayegh, Valentina Guarneri, Kimberly Desrouleaux, Jeffrey Cui, Andrea Adamus, Robert F Gagel and Gabriel N Hortobagyi

    Article first published online : 4 FEB 2008, DOI: 10.1359/jbmr.080205

  18. You have free access to this content
    ASBMR 31st Annual Meeting FR0001–FR0464

    Journal of Bone and Mineral Research

    Volume 24, Issue S1, 2009, Pages: S94–S149,

    Article first published online : 16 JUN 2011, DOI: 10.1002/jbmr.5650241302

  19. Bone microenvironment-related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC-3 prostate cancer cells

    The Prostate

    Volume 59, Issue 2, 1 May 2004, Pages: 120–131, Roxane Tenta, Despina Tiblalexi, Evangelia Sotiriou, Peter Lembessis, Menelaos Manoussakis and Michael Koutsilieris

    Article first published online : 11 DEC 2003, DOI: 10.1002/pros.10363

  20. You have free access to this content
    ASBMR 2010 Annual Meeting SU0001–SU0482

    Journal of Bone and Mineral Research

    Volume 25, Issue S1, 2010, Pages: S225–S362,

    Article first published online : 16 JUN 2011, DOI: 10.1002/jbmr.5650251304